
Updates from the 2006 annual meeting of the American Society of Clinical Oncology.
Updates from the 2006 annual meeting of the American Society of Clinical Oncology.
Young adult survivor Molly McMaster turns her experience into a national tour and non-profit group dedicated to raising awareness on colon cancer.
Eight years after its approval, Herceptin emerges as the best weapon against HER2-positive breast cancer.
A closer look at bioidentical hormones and why one pharmaceutical company wants the FDA to keep a closer eye on them.
From mastectomy to reconstruction and beyond.
The challenges of breast cancer in women under 40.
The progress made in genetic testing for breast cancer.
Women with a history of breast cancer should not take HRT.